Using Pharmacogenetics and Advanced Neuroscience to Personalize Treatment of Psychiatric Illness. Issue 44 (January 2015)

• Record Type: Journal Article
• Authors: Rizzo, Toni
• Other Names: Leahy Laura G. presenter.
• Is Part Of: MD conference express. Volume 14:Issue 44(2014)
• Page Start: 2
• Page End: 4
• Publication Date: 2015-01
• Subjects: Psychopharmacology; Psychiatry -- Psychopharmacology; Medicine -- Congresses; 610
• DOI: 10.1177/155989771444001
• Languages: English
• ISSNs: 1559-8977

Abstract

In any given year, 26.2% of individuals in the United States experience a diagnosable psychiatric illness. Approximately 6% of adults suffer from a seriously debilitating mental illness. Among adolescents aged 13 to 18 years, 46.3% experience symptoms of psychiatric illness, and 21.4% experience a severe disorder. This article discusses clinical tools for personalizing psycho-pharmacologic treatment, including psychopharmacogenetics, laboratory studies, review of systems, symptom evaluation, and observation.